Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Church

Showing results (391-400 of 464) with videos related to

Pageof 47
Sort By:
Pediatrics|August 1, 1995
A phase I/II evaluation of stavudine (d4T) in children with human immunodeficiency virus infectionM W Kline, L M Dunkle, J A Church, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 7, 2008
The maturing architecture of the brain's default networkDamien A Fair, Alexander L Cohen, Nico U F Dosenbach, et al.
Pediatrics|January 3, 2001
A randomized, double-blind study of triple nucleoside therapy of abacavir, lamivudine, and zidovudine versus lamivudine and zidovudine in previously treated human immunodeficiency virus type 1-infected children. The CNAA3006 Study TeamX Sáez-Llorens, R P Nelson, P Emmanuel, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|June 30, 2007
Safety and outcomes of balloon catheter sinusotomy: a multicenter 24-week analysis in 115 patientsWilliam E Bolger, Christopher L Brown, Christopher A Church, et al.
AIDS (London, England)|January 6, 2016
Supranormal thymic output up to 2 decades after HIV-1 infectionChristian R Aguilera-Sandoval, Otto O Yang, Nebojsa Jojic, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1998
Serum and cerebrospinal fluid pharmacokinetics of intravenous and oral lamivudine in human immunodeficiency virus-infected childrenB U Mueller, L L Lewis, G J Yuen, et al.
International Journal of Epidemiology|December 7, 2021
Prevalence, risk factors and short-term consequences of adverse birth outcomes in Zimbabwean pregnant women: a secondary analysis of a cluster-randomized trialBernard Chasekwa, Robert Ntozini, James A Church, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2007
Development of distinct control networks through segregation and integrationDamien A Fair, Nico U F Dosenbach, Jessica A Church, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 18, 2020
Exclusive enteral nutrition induced sustained changes in the microbiota and improved inflammatory bowel disease in a pediatric patient with chronic granulomatous diseaseEmilia Liana Falcone, Yu Han, Samantha Kreuzburg, et al.
Journal of Clinical Immunology|March 7, 2012
Safety, efficacy and pharmacokinetics of a new 10% liquid intravenous immunoglobulin (IVIG) in patients with primary immunodeficiencyRichard L Wasserman, Joseph A Church, Mark Stein, et al.
Pageof 47

Showing results (391-400 of 464) with videos related to

Sort By:
Pageof 47
Pediatrics|August 1, 1995
A phase I/II evaluation of stavudine (d4T) in children with human immunodeficiency virus infectionM W Kline, L M Dunkle, J A Church, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 7, 2008
The maturing architecture of the brain's default networkDamien A Fair, Alexander L Cohen, Nico U F Dosenbach, et al.
Pediatrics|January 3, 2001
A randomized, double-blind study of triple nucleoside therapy of abacavir, lamivudine, and zidovudine versus lamivudine and zidovudine in previously treated human immunodeficiency virus type 1-infected children. The CNAA3006 Study TeamX Sáez-Llorens, R P Nelson, P Emmanuel, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|June 30, 2007
Safety and outcomes of balloon catheter sinusotomy: a multicenter 24-week analysis in 115 patientsWilliam E Bolger, Christopher L Brown, Christopher A Church, et al.
AIDS (London, England)|January 6, 2016
Supranormal thymic output up to 2 decades after HIV-1 infectionChristian R Aguilera-Sandoval, Otto O Yang, Nebojsa Jojic, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1998
Serum and cerebrospinal fluid pharmacokinetics of intravenous and oral lamivudine in human immunodeficiency virus-infected childrenB U Mueller, L L Lewis, G J Yuen, et al.
International Journal of Epidemiology|December 7, 2021
Prevalence, risk factors and short-term consequences of adverse birth outcomes in Zimbabwean pregnant women: a secondary analysis of a cluster-randomized trialBernard Chasekwa, Robert Ntozini, James A Church, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2007
Development of distinct control networks through segregation and integrationDamien A Fair, Nico U F Dosenbach, Jessica A Church, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 18, 2020
Exclusive enteral nutrition induced sustained changes in the microbiota and improved inflammatory bowel disease in a pediatric patient with chronic granulomatous diseaseEmilia Liana Falcone, Yu Han, Samantha Kreuzburg, et al.
Journal of Clinical Immunology|March 7, 2012
Safety, efficacy and pharmacokinetics of a new 10% liquid intravenous immunoglobulin (IVIG) in patients with primary immunodeficiencyRichard L Wasserman, Joseph A Church, Mark Stein, et al.
Pageof 47